Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses
While T cells recognise the complex of peptide and major histocompatibility complex (MHC) at the cell surface, changes in the dose and/or structure of the peptide component can have profound effects on T cell activation and function. In addition, the repertoire of T cells capable of responding to an...
Main Author: | Graham R. Leggatt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/2/3/537 |
Similar Items
-
High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence
by: Laura Carretero-Iglesia, et al.
Published: (2020-01-01) -
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
by: Benedikt Judmann, et al.
Published: (2020-07-01) -
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis
by: Rolf Billeskov, et al.
Published: (2018-01-01) -
AVIDITY EVALUATION OF LOCAL IgA ANTIBODIES IN PERSONS IMMUNIZED WITH LIVE INFLUENZA VACCINE
by: S. A. Donina, et al.
Published: (2014-07-01) -
Malaria parasite interactions with the human host
by: Pouniotis D, et al.
Published: (2004-01-01)